Use of Pan-Vascular Endothelial Growth Factor Receptor (Pan-VEGF) Blockade for the Treatment of Retinopathy of Prematurity (ROP) (Compassionate Use BLOCK-ROP)
Expanded access is temporarily not available for this treatment.
Sponsor:
Children's Hospital Los Angeles
Information provided by:
Children's Hospital Los Angeles
ClinicalTrials.gov Identifier:
NCT00870636
First received: March 26, 2009
Last updated: March 27, 2009
Last verified: March 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | Expanded access is temporarily not available for this treatment. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | No date given |